Item 7. Management’s Discussion and Analysis
ITEM
7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References
in this report to “we,” “us” or the “Company” refer to INFINT
Acquisition Corporation . References to our “management” or our “management team” refer to our officers
and directors, and references to the “Sponsor” refer to InFinT Capital LLC. The following discussion and analysis of the
Company’s financial condition and results of operations should be read in conjunction with the annual financial statements and
the notes thereto contained elsewhere in this Report. Certain information contained in the discussion and analysis set forth below includes
forward-looking statements that involve risks and uncertainties.
57
Cautionary
Note Regarding Forward-Looking Statements
All
statements other than statements of historical fact included in this Annual Report including, without limitation, statements under “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” regarding our financial position, business strategy and
the plans and objectives of management for future operations, are forward looking statements. When used in this Annual Report, words
such as “may,” “should,” “could,” “would,” “expect,” “plan,”
“anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other
similar expressions, as they relate to us or our management, identify forward looking statements. Such forward looking statements are
based on the beliefs of management, as well as assumptions made by, and information currently available to, our management. No assurance
can be given that results in any forward-looking statement will be achieved and actual results could be affected by one or more factors,
which could cause them to differ materially. The cautionary statements made in this Annual Report should be read as being applicable
to all forward-looking statements whenever they appear in this Annual Report. For these statements, we claim the protection of the safe
harbor for forward-looking statements contained in the Private Securities Litigation Reform Act. Actual results could differ materially
from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to, those detailed
in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf
are qualified in their entirety by this paragraph.
Business
Combination Agreement; Extensions; NYSE Notice
On
August 3, 2022, the Company, entered into the Business
Combination Agreement with Merger Sub, and Seamless. If the Business Combination Agreement is approved by the Company’s shareholders
(and the other closing conditions are satisfied or waived in accordance with the Business Combination Agreement), and the transactions
contemplated by the Business Combination Agreement are consummated, Merger Sub will merge with and into Seamless, with Seamless surviving
the Merger as a wholly owned subsidiary of the Company (such transactions are referred to collectively as the “Proposed Transactions”).
Under the Business Combination Agreement, Seamless Shareholders are expected to receive $400,000,000 (“Seamless Value”) in
aggregate consideration in the form of ordinary shares of the Company, par value $0.0001 per share equal to the quotient obtained by
dividing (i) the Seamless Value by (ii) $10.00. The Business
Combination Agreement was amended on October 20, 2022, November 29, 2022 and February 20, 2023.
Concurrently
with the execution of the Business Combination Agreement, the Company, Seamless Shareholders and Seamless entered into the Shareholder
Support Agreement, pursuant to which, among other things, such Seamless Shareholders party thereto agreed to (a) vote their Seamless
shares in support and favor of the Business Combination Agreement, the Proposed Transactions and all other matters or resolutions that
could reasonably be expected to facilitate the Proposed Transactions, (b) waive any dissenters’ rights in connection with the Proposed
Transactions, (c) not transfer their respective Seamless shares and (d) terminate the Seamless’ shareholders’ agreement at
or prior to closing.
Concurrently
with the execution of the Business Combination Agreement, Sponsor, the Company and Seamless had entered into the Sponsor Support Agreement,
pursuant to which, among other things, Sponsor agreed to (a) vote at the Company’s shareholder meeting in favor of the Business
Combination Agreement and the Proposed Transactions, (b) abstain from redeeming any Sponsor founder shares in connection with the Proposed
Transactions, and (c) waive certain anti-dilution provisions contained in the Company’s Charter.
On
November 22, 2022, Seamless deposited additional funds in the amount of $2,999,982 to the Trust Account to automatically extend the date
by with the Company must consummate a business combination from November 23, 2022 to February 23, 2023. On February 13, 2023, at the
extraordinary general meeting the Company’s shareholders approved the First Extension to extend the date that the Company has to consummate a business combination from February 23, 2023 to the First Extended Date.
Under Cayman Islands law, the amendment to the Charter took effect upon approval of the First Extension.
In
connection with the votes to approve the First Extension, the holders of 10,415,452 Class A ordinary shares of the Company
properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.49 per share, for an
aggregate redemption amount of approximately $109.31 million, leaving approximately $100.59 million in the Trust Account.
In
accordance with the Business Combination Agreement, as amended, additional funds in the amount of $290,000 were deposited by Seamless
to the Trust Account on February 21, 2023, and the required contributions continued to be deposited on or before the 23rd day of each
subsequent calendar month into the Trust Account until August 23, 2023.
On
August 18, 2023, the Company’s shareholders approved the Second Extension to amend the Charter to extend the date by which it has
to consummate a Business Combination from August 23, 2023 to the Second Extended Date. Under
Cayman Islands law, the amendment to the Charter took effect upon approval of the proposal to amend the Charter. In connection with the
votes to approve the proposal to amend the Charter, the holders of 2,176,003 Class A ordinary shares of the Company properly exercised
their right to redeem their shares for cash at a redemption price of approximately $10.94 per share (the “August 2023 Redemption”),
for an aggregate redemption amount of approximately $23.8 million, leaving approximately $81.1 million in the Company’s Trust Account.
In
accordance with the Business Combination Agreement, as amended, additional funds in the amount of $160,000 were deposited by Seamless
to the Trust Account on September 19, 2023, and the required contributions continued to be deposited on or before the 23rd day of each
subsequent calendar month into the Trust Account until the Second Extended Date.
On
February 16, 2024, the Company’s shareholders approved to the Third Extension to extend the date by which it has to consummate
a Business Combination from February 23, 2024 to the Third Extended Date. Under Cayman Islands
law, the amendment to the Charter took effect upon approval of the proposal to amend the Charter. In connection with the votes to approve
the proposal to amend the Charter, the holders of 2,661,404
Class A ordinary shares of the Company properly exercised their right to redeem their shares for
cash at a redemption price of approximately $11.36 per share (the “August 2023 Redemption”), for an aggregate redemption
amount of approximately $ 30.26 million, leaving approximately $53.97 million in the Company’s
Trust Account. Accordingly, the Company now has until the Third Extended Date to consummate its initial business combination.
In
accordance with the Business Combination Agreement, as amended, additional funds in the amount of $80,000 were deposited by Seamless
to the Trust Account on February 20, 2024, and the required contributions will continue to be deposited on or before the 23rd day of
each subsequent calendar month into the Trust Account until the Third Extended Date or the date an initial business combination is completed.
On
January 19, 2024, the Company received the Notice from the NYSE informing us that, because the number of public shareholders is less than 300,
INFINT is not in compliance with Section 802.01B of the Listing Rule. The Listing Rule requires INFINT to maintain a minimum of 300 public
stockholders on a continuous basis. The Notice specifies that INFINT has 45 days to submit a business plan that demonstrates how INFINT
expects to return to compliance with the Listing Rule within 18 months of receipt of the Notice. On March 4, 2024, the Company submitted such
a business plan to demonstrate how INFINT expects to return to compliance with the Listing Rule within 18 months of receipt of the Notice.
58
Results
of Operations
Our
only activities through December 31, 2023 were organizational activities, those necessary to consummate the IPO, described below, and
identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion
of our Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust
Account. We are incurring expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance),
as well as for due diligence expenses.
For
the year ended December 31, 2023, we had net income of $3,147,500, which consisted of operating costs of $2,027,707, offset by interest
earned on marketable securities held in the Trust Account of $5,175,207.
For
the year ended December 31,2022, we had net loss of $1,111,964, which consisted of operating costs of $4,044,156, offset by interest
earned on marketable securities held in the Trust Account of $2,932,192.
Liquidity
and Capital Resources
On
November 23, 2021, the Company consummated its IPO of 17,391,200 of its units. Each Unit consists of one Class A ordinary share, $0.0001
par value per share, and one-half of one redeemable warrant, with each whole warrant entitling the holder to purchase one ordinary share
at a price of $11.50 per share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $173,912,000.
Simultaneously
with the consummation of the IPO, the Company consummated the private placement of 7,032,580 warrants at a price of $1.00 per Private
Warrant, generating total proceeds of $7,032,580, to the Company’s Sponsor. The Private Warrants are identical to the warrants
sold in the IPO.
On
November 23, 2021, the Company consummated the sale of an additional 764,262 Private Warrants in connection with the underwriter’s
exercise of its over-allotment option to purchase an additional 2,608,680 Units for gross proceeds of $26,086,800. The Private Warrants
were sold at $1.00 per Private Warrant, generating additional gross proceeds of $764,262. Following the closing of the over-allotment
option, the Company generated total gross proceeds of $207,795,642 from the IPO and the Private Placement, of which the Company raised
$199,998,800 in the IPO, $7,796,842 in the Private Placement and of which $202,998,782 was placed in the Company’s Trust Account
established in connection with the IPO.
For
the year ended December 31, 2023, cash used in operating activities was $552,958. Net income of $3,147,500 was offset by interest earned
on marketable securities held in the Trust Account of $5,175,207. Changes in operating assets and
liabilities used $1,474,749 of cash for operating activities. Cash from investing activities consisted of cash withdrawn from the trust
account of $133,124,975 net with additional investments in the trust account of $2,540,000. Cash used in financing activities consisted
of the redemption of ordinary shares of $133,124,975 net with contributions for the extension of $2,540,000 and proceeds from working
capital loan of $325,000.
For
the year ended December 31, 2022, cash used in operating activities was $(756,716). Net loss of $1,111,964 was offset by interest earned
on marketable securities held in the Trust Account of $2,932,192. Changes in operating assets and liabilities used $3,287,440 of cash
for operating activities.
At
December 31, 2023, we had marketable securities held in the Trust Account of $ 83,523,112
consisting of securities held in a money market fund and government bonds that invests in United States government treasury bills, bonds
or notes with a maturity of 185 days or less. Through December 31, 2023, we did not withdraw any interest earned on the Trust Account
to pay our taxes. The amount of funds available for a business combination is approximately $83.5 million after payment of $5,999,964
of deferred underwriting fees and payment of an aggregate redemption amount of approximately $133.1 million as a result of the approval
of the Extension Proposals. To the extent that our capital stock is used in whole or in part as consideration to effect a Business Combination,
the remaining funds held in the Trust Account will be used as working capital to finance the operations of the target business. Such
working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for
strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also be used to repay
any operating expenses or finders’ fees which we had incurred prior to the completion of our Business Combination if the funds
available to us outside of the Trust Account were insufficient to cover such expenses.
At
December 31, 2023, we have available to us $ 43,509 of cash on our operating account and
working capital deficit of $ 4,516,047 . We will use these funds primarily to find and evaluate
target businesses, perform business, legal, and accounting due diligence on prospective target businesses, travel to and from the offices,
plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material
agreements of prospective target businesses, and structure, negotiate and complete a business combination. The interest income earned
on the investments in our Trust Account are unavailable to fund operating expenses.
59
In
order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor,
or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working
Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation
of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation
of a Business Combination into additional private placement warrants at a price of $1.00 per warrant. In the event that a Business Combination
does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans.
On
September 13, 2023, the Company issued an unsecured promissory note (the “Note”) in the principal amount of up to $400,000
to the Sponsor, which may be drawn down from time to time prior to the Maturity Date (as defined below) upon request by the Company.
The Note amended, replaced and superseded in its entirety that certain promissory note, dated May 1, 2023, made by the Company in favor
of the Sponsor in the principal amount of up to $150,000 (the “Original Note”), and any unpaid principal balance of the indebtedness
evidenced by the Original Note has been merged into and evidenced by the Note. The Note does not bear interest and the principal balance
will be payable on the date on which the Company consummates its initial business combination (such date, the “Maturity Date”).
In the event the Company consummates its initial business combination, the Sponsor has the option on the Maturity Date to convert the
principal outstanding under the Note into that number of private placement warrants (“Working Capital Warrants”) equal to
the portion of the principal amount of the Note being converted divided by $1.00, rounded up to the nearest whole number. The terms of
the Working Capital Warrants, if any, would be identical to the terms of the private placement warrants issued by the Company at the
time of its IPO, as described in the prospectus for the IPO, dated November 22, 2021 and filed with the SEC, including the transfer restrictions
applicable thereto. The Note is subject to customary events of default, the occurrence of certain of which automatically triggers the
unpaid principal balance of the Note and all other sums payable with regard to the Note becoming immediately due and payable. As of December
31, 2023, $325,000 was outstanding pursuant to the Note.
On
March 6, 2024, the Company issued an unsecured promissory note (the “Seamless Note”) in the principal amount of up to $500,000
to Seamless, which may be drawn down from time to time prior to the Maturity Date (upon request by the Company. The Seamless Note does
not bear interest and the principal balance will be payable on the Maturity Date. The Seamless Note is subject to customary events of
default, the occurrence of certain of which automatically triggers the unpaid principal balance of the Second Note and all other sums
payable with regard to the Seamless Note becoming immediately due and payable.
We
will have until the Third Extended Date to consummate our initial business combination. On February 13, 2023, the Company’s
shareholders approved the First Extension. Under Cayman Islands law, the amendment to the Charter took effect upon approval
of the First Extension. In connection with the votes to approve the First Extension, the holders of 10,415,452 Class A
ordinary shares of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately
$10.49 per share, for an aggregate redemption amount of approximately $109.31 million, leaving approximately $100.59 million in the
Trust Account.
On
August 18, 2023, the Company’s shareholders approved to the Second Extension to extend the date by which it has to consummate a
Business Combination from August 23, 2023 to the Second Extended Date. In connection with the
votes to approve the Second Extension, the holders of 2,176,003 Class A ordinary shares of the Company properly exercised their right
to redeem their shares for cash at a redemption price of approximately $10.94 per share, for an aggregate redemption amount of approximately
$23.8 million, leaving approximately $81.1 million in the Company’s Trust Account.
On
February 16, 2024, the Company’s shareholders approved the Third Extension to extend the date by which it has to consummate a Business
Combination from February 23, 2024 to the Third Extended Date. Accordingly, the Company now
has until the Third Extended Date to consummate its initial business combination. In connection with the votes to approve the Third Extension,
the holders of 2,661,404 Class A ordinary shares of the Company properly exercised their right to redeem their shares for cash at a redemption
price of approximately $11.36 per share, for an aggregate redemption amount of approximately $30.26 million, leaving approximately $53.97
million in the Company’s Trust Account.
Based
on the foregoing, management believes that the Company expects to continue to incur significant costs in pursuit of the consummation
of a Business Combination. The Company’s liquidity needs prior to the consummation of the Initial Public Offering had been satisfied
through proceeds from notes payable and from the issuance of common stock. However, the $43,509 in cash is unlikely to be be sufficient to allow
the Company to operate for at least the next 12 months from the issuance of the financial statements. Additionally, the combination period
is less than one year from the date of the issuance of the financial statements. As a result, there is substantial doubt that the Company
can sustain operations for a period of at least one-year from the issuance date of these financial statements.
Our
only activities through December 31, 2023 were organizational activities, those necessary to consummate the IPO,
described below, and identifying a target company and preparing for the Business Combination. We do not expect to generate any operating
revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income on marketable
securities held in the Trust Account. We are incurring expenses as a result of being a public company (for legal, financial reporting,
accounting and auditing compliance), as well as for due diligence expenses.
Off-Balance
Sheet Financing Arrangements
We
have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of December 31, 2023. We do not
participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable
interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered
into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other
entities, or purchased any non-financial assets.
Contractual
Obligations
We
do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities other than an agreement
to pay our Sponsor a monthly fee of $10,000 for office space, utilities and secretarial and administrative support. We began incurring
these fees on November 23, 2021 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination
and our liquidation.
60
In
connection with our initial business combination, we are obligated to pay our expenses relating thereto, including the deferred underwriting
commission payable to our underwriter in an amount equal to 3.0% of the total gross proceeds raised in the offering, or $5,999,964, upon
consummation of our initial business combination.
Critical
Accounting Estimates
The
preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial
statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have
identified the following critical accounting policies:
Class
A ordinary shares subject to possible redemption
The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing
Liabilities from Equity ”. Ordinary shares subject to mandatory redemption are classified as a liability instrument and are
measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either
within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s
control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s
Class A ordinary shares feature certain redemption rights that are considered by the Company to be outside of the Company’s control
and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2023, the Class A ordinary shares subject to possible
redemption in the amount of $83,523,112 are presented as temporary equity, outside of the shareholders’ equity section of the
Company’s balance sheet.
Warrants
The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s
specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common
stock, among other conditions for equity classification. This assessment, which requires the use of professional judgement, is conducted
at the time of warrant issuance and is re-evaluated as of each subsequent quarterly period end date while the warrants are outstanding.
The Company concluded that the warrants should be classified as equity.
Net
loss per ordinary share
The
Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net loss per share is
computed by dividing net loss by the weighted average number of ordinary share outstanding during the period, excluding ordinary share
subject to forfeiture. At December 31, 2023, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into ordinary share and then share in the earnings of the Company. As a result, diluted loss per share is the
same as basic loss per share for the periods presented.
Recent
Accounting Standards
Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on our financial statements.
Item
7A. Quantitative and Qualitative Disclosures about Market Risk
Not
required for smaller reporting companies.
ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
This
information appears following Item 16 of this Annual Report and is included herein by reference.
Item
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
61
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.